Epilepsy & Frontotemporal Dementia Link
- A recent study reveals that epileptic seizures are significantly more prevalent in patients with frontotemporal dementia (FTD) than previously understood.
- The research, published in JAMA Neurology, analyzed data from university hospitals in Kuopio and Oulu between 2010 and 2021.
- Annemari Kilpeläinen, the study's first author and a neurology specialist, stated, "Our results show that epilepsy is considerably more common among those with FTD than those with Alzheimer's...
The study found that epileptic seizures are much more prevalent in frontotemporal dementia (FTD) patients than previously believed, signaling crucial implications for treatment. This groundbreaking research, published in JAMA Neurology by Neurocenter Finland, examined thousands of medical records and revealed that epilepsy can surface years before an official FTD diagnosis. Considering that approximately 11% of FTD patients experience epilepsy even five years after diagnosis, the need for proactive monitoring and treatment is clear. This link between epilepsy and FTD, a serious memory disorder, offers new research paths, including the possibility of shared pathological mechanisms and whether symptoms are, in fact, connected to the same electrical systems of the brain. News Directory 3 is following the story. Discover what’s next as researchers explore these engaging connections.
Epilepsy More Common in Frontotemporal Dementia Patients, Study Finds
A recent study reveals that epileptic seizures are significantly more prevalent in patients with frontotemporal dementia (FTD) than previously understood. This finding, coordinated by Neurocenter Finland involving the University of Eastern Finland and the University of Oulu, emphasizes the need to consider epilepsy when treating and monitoring FTD, a memory disorder.
The research, published in JAMA Neurology, analyzed data from university hospitals in Kuopio and Oulu between 2010 and 2021. Researchers examined 12,490 medical records,identifying 245 FTD patients and 1,326 Alzheimer’s disease patients,along with a control group.
Annemari Kilpeläinen, the study’s first author and a neurology specialist, stated, “Our results show that epilepsy is considerably more common among those with FTD than those with Alzheimer’s disease or in healthy controls.”
Notably, epilepsy sometimes appeared up to a decade before the FTD diagnosis and was more common across all disease stages than indicated by prior international research. The study assessed epilepsy prevalence at various points, from 10 years before to five years after dementia diagnosis. Approximately 11% of FTD patients had epilepsy five years post-diagnosis. The increased use of epilepsy medication among FTD patients further validates these findings.
Eino Solje, the project’s principal investigator, said identifying epilepsy is important because its treatment can improve patients’ functional capacity and quality of life. Knowledge about the association between epilepsy and FTD raises new research questions: do these diseases share some pathophysiological mechanisms and could some FTD symptoms be caused by alterations in the specific electrical systems of the brain.
What’s next
The study is part of a larger project combining extensive patient data with unique registers, fostering collaboration between the University of Oulu and the University of Eastern Finland, bridging medicine and law. kuopio University Hospital and Oulu University Hospital are part of the European Reference Network EpiCARE.
